ASTRAZENECA PHARMA INDIA
Quarterly Results Analysis [Sep2024]
ASTRAZENECA PHARMA INDIA Quarterly Results
Standalone | Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹408 Cr | ₹388 Cr | ₹383 Cr | ₹306 Cr | ₹311 Cr | ₹295 Cr | ₹285 Cr | ₹250 Cr |
Expenses | ₹355 Cr | ₹349 Cr | ₹334 Cr | ₹291 Cr | ₹258 Cr | ₹228 Cr | ₹225 Cr | ₹213 Cr |
Operating Income | ₹53 Cr | ₹38 Cr | ₹49 Cr | ₹15 Cr | ₹53 Cr | ₹67 Cr | ₹60 Cr | ₹37 Cr |
Other Income | ₹8 Cr | ₹8 Cr | ₹9 Cr | ₹10 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹7 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹9 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
Profit Before Tax | ₹51 Cr | ₹-15 Cr | ₹54 Cr | ₹20 Cr | ₹73 Cr | ₹71 Cr | ₹23 Cr | ₹39 Cr |
Profit After Tax | ₹38 Cr | ₹-12 Cr | ₹39 Cr | ₹16 Cr | ₹52 Cr | ₹54 Cr | ₹17 Cr | ₹29 Cr |
EPS | ₹15.37 | ₹-4.72 | ₹15.79 | ₹6.32 | ₹20.95 | ₹21.54 | ₹6.91 | ₹11.72 |
Industry Peers & Returns | 1W | 1M | 1Y |
ASTRAZENECA PHARMA INDIA | -1.9% | -1.9% | 19.3% |
SUN PHARMACEUTICAL INDUSTRIES | 2.9% | 6.4% | 48.1% |
CIPLA | 2.3% | 1% | 20.6% |
DR REDDYS LABORATORIES | 3.5% | 15.7% | 20.3% |
ZYDUS LIFESCIENCES | -0.1% | 2.3% | 41.1% |
DIVIS LABORATORIES | 0.5% | -2.1% | 59.2% |
MANKIND PHARMA | 2.5% | 12.4% | 50.8% |
TORRENT PHARMACEUTICALS | -0.8% | 5.7% | 54.3% |
LUPIN | 3.8% | 11.1% | 72.6% |
ASTRAZENECA PHARMA INDIA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 5.28 % |
Y-o-Y | 31.16 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹408 Cr | 5.28 | |
Jun2024 | ₹388 Cr | 1.13 | |
Mar2024 | ₹383 Cr | 25.31 | |
Dec2023 | ₹306 Cr | -1.70 | |
Sep2023 | ₹311 Cr | 5.28 | |
Jun2023 | ₹295 Cr | 3.78 | |
Mar2023 | ₹285 Cr | 13.97 | |
Dec2022 | ₹250 Cr | - |
ASTRAZENECA PHARMA INDIA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 38.01 % |
Y-o-Y | -0.42 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹53 Cr | 38.01 | |
Jun2024 | ₹38 Cr | -22.92 | |
Mar2024 | ₹49 Cr | 228.03 | |
Dec2023 | ₹15 Cr | -71.46 | |
Sep2023 | ₹53 Cr | -21.53 | |
Jun2023 | ₹67 Cr | 12.35 | |
Mar2023 | ₹60 Cr | 63.57 | |
Dec2022 | ₹37 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 31.16 % |
Y-o-Y | -24.06 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | 12.88% | 31.16 | |
Jun2024 | 9.82% | -23.82 | |
Mar2024 | 12.89% | 161.99 | |
Dec2023 | 4.92% | -70.99 | |
Sep2023 | 16.96% | -25.48 | |
Jun2023 | 22.76% | 8.28 | |
Mar2023 | 21.02% | 43.48 | |
Dec2022 | 14.65% | - |
ASTRAZENECA PHARMA INDIA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | Positive |
Y-o-Y | -26.62 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹38 Cr | Positive | |
Jun2024 | ₹-12 Cr | Negative | |
Mar2024 | ₹39 Cr | 149.86 | |
Dec2023 | ₹16 Cr | -69.83 | |
Sep2023 | ₹52 Cr | -2.77 | |
Jun2023 | ₹54 Cr | 211.85 | |
Mar2023 | ₹17 Cr | -41.07 | |
Dec2022 | ₹29 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | Positive |
Y-o-Y | -44.06 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | 9.42 % | Positive | |
Jun2024 | -3.04 % | Negative | |
Mar2024 | 10.3 % | 99.23 | |
Dec2023 | 5.17 % | -69.30 | |
Sep2023 | 16.84 % | -7.62 | |
Jun2023 | 18.23 % | 200.33 | |
Mar2023 | 6.07 % | -48.25 | |
Dec2022 | 11.73 % | - |
ASTRAZENECA PHARMA INDIA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | Positive |
Y-o-Y | -26.63 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹15.37 | Positive | |
Jun2024 | ₹-4.72 | Negative | |
Mar2024 | ₹15.79 | 149.84 | |
Dec2023 | ₹6.32 | -69.83 | |
Sep2023 | ₹20.95 | -2.74 | |
Jun2023 | ₹21.54 | 211.72 | |
Mar2023 | ₹6.91 | -41.04 | |
Dec2022 | ₹11.72 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD